China .. a new genetic treatment that restores the audience for children with deafness

A child with deafness could hear for the first time thanks to a genetic treatment developed by Chinese and American researchers, in a move that restores the hope for these people with a rare genetic mutation. It is now possible for Chu Yang Yang (3 years) to call his parents and call the colors, and he was just a few months ago. This boy is one of the five children who managed to hear for the first time thanks to the revolutionary genetic therapy he received as part of a clinical trial conducted by Chinese and US researchers. A turning point in the treatment of deafness and the detail of this study, published on Wednesday in the journal Nature Medicine, the results of the first application of this genetic therapeutic procedure on the ears. This procedure has led to a better awareness of the language and the greater ability to find the source of the sound; Provided by one over -treatment. The researcher at Eiton Pepadi Zingi Yi Chen explained that this study, which was responsible for it as a “decisive turning point”, added that companies do clinical studies, including two in Boston, to obtain a permit using treatment. He added: “If the results remain as they are, and no complications are monitored, I think the procedure can get approval within 3 to 5 years.” Genetic therapy and side effects, about 26 million people suffer from a genetic form of deafness all over the world, and this genetic therapy focuses on a museum that suffers between 2 and 8% of cases. These patients cannot produce autopperlin, a protein that needs capillary cells in the inner ear to convert audio vibrations into chemical signals sent to the brain. The procedure is based on an average virus in the inner ear, which reflects the Deaf Causing Museum. “All family members”, including the mother of Chu Yang Yang and his grandmother, said, “They realized that the child could hear for the first time,” said Yilai Show, who participated in the preparation of the study. Researcher Shaw previously managed a research team in 2022 after the first genetic treatment of this nature currently given to many children in the world, such as in the United States and Britain. He said that the treatment of ears poses new problems because doubling surgery increases the risk of side effects. But only light or medium side effects, such as fever, vomiting or a slight increase in white blood cells, were recorded. There was a great progress in the five children between the ages of one to 11 years, and two of them managed to listen to music, although it is more difficult to hear this sound sign. The 11 -year -old could also understand the language more and speak better, despite the prevailing belief that it is too late for the brain to get this ability, as it has not heard noises before. “Evidence that the brain has flexibility that can last longer than initially believed,” he said. While the researchers have announced that they have launched clinical tests on animals to achieve treatments against other causes of genetic deafness, including those associated with the gene causing the most common deafness at birth. The World Health Organization reported that by 2050, about 2.5 billion people were expected to suffer from hearing loss, and that at least 700 million people would need rehabilitation to address hearing problems. She pointed out that there are more than a billion young men who are the risk of permanent hearing loss, which can be avoided as a result of their unsafe listening practices.